Co-authors (19)

Journals (2)

Keywords (13)

Embed

Subscribe

Academic

Yoshiaki Kigawa

Yoshiaki Kigawa,Family Medicine

Yoshiaki Kigawa

Publications: 7 | Citations: 30

Fields: Family Medicine

Collaborated with 19 co-authors from 2002 to 2008 | Cited by 83 authors

Cumulative Annual

Sort by:

Publications (7)

BibTeX | RIS | RefWorks Download

Lack of Relationship between Blood Glucose-lowering Activity of Colestimide and Serum Cholecystokinin (CCK) Concentrations in Patients with Type 2 Diabetes

, , , , , , , , ,

Journal: Journal of Nippon Medical School , vol. 75, no. 2, pp. 111-115, 2008

Daily blood glucose profiles of glibenclamide and gliclazide taken once or twice daily in elderly type 2 diabetic patients

, , , , , , , , ,

Journal: Geriatrics & Gerontology International - GERIATR GERONTOL INT , vol. 8, no. 3, pp. 160-165, 2008

Colestimide Lowers Plasma Glucose Levels and Increases Plasma Glucagon-like Peptide1 (7-36) Levels in Patients with Type 2 Diabetes Mellitus Complicated by Hypercholesterolemia (Citations: 15)

, , , , , , , , , ,

Journal: Journal of Nippon Medical School , vol. 74, no. 5, pp. 338-343, 2007

The Effects of Colestimide on Blood Glucose-lowering Activity and Body Weight in Patients with Type 2 Diabetes and Hypercholesterolemia (Citations: 2)

, , , , , , , , ,

Journal: Journal of Nippon Medical School , vol. 74, no. 1, pp. 81-84, 2007

Blood Glucose-lowering Activity of Colestimide in Patients with Type 2 Diabetes and Hypercholesterolemia: A Case-control Study Comparing Colestimide with Acarbose (Citations: 8)

, , , , , , , , ,

Journal: Journal of Nippon Medical School , vol. 73, no. 5, pp. 277-284, 2006

Sort by:

Citations (30 times by 25 publications)

Colesevelam lowers glucose and lipid levels in type 2 diabetes: the clinical evidence (Citations: 5)

, ,

Journal: Diabetes Obesity & Metabolism - DIABETES OBES METAB , vol. 12, no. 5, pp. 384-392, 2010

Improved glycemic control with colesevelam treatment in patients with type 2 diabetes is not directly associated with changes in bile acid metabolism (Citations: 3)

, , , , , , ,

Journal: Hepatology , 2010

Bile Acid Sequestrants for Lipid and Glucose Control (Citations: 1)

, ,

Journal: Current Diabetes Reports - CURR DIABETES REP , vol. 10, no. 1, pp. 70-77, 2010

Molecular pathways and agents for lowering LDL-cholesterol in addition to statins (Citations: 2)

Journal: Pharmacology & Therapeutics - PHARMACOL THER , vol. 126, no. 3, pp. 263-278, 2010

Treatment of dyslipidemia in patients with type 2 diabetes

Journal: Lipids in Health and Disease - LIPIDS HEALTH DIS , vol. 9, no. 1, pp. 144-12, 2010

Comments